Literature DB >> 12823503

Cyclosporine-related posterior reversible encephalopathy syndrome (PRES) in non-transplant patient: a case report and literature review.

M Cosottini, G Lazzarotti, R Ceravolo, M C Michelassi, R Canapicchi, L Murri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12823503     DOI： 10.1046/j.1468-1331.2003.00608_1.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  4 in total

1.  Posterior reversible encephalopathy syndrome (PRES) induced by cyclosporine use in a patient with collapsing focal glomeruloesclerosis.

Authors:  Rodrigo Alves de Oliveira; Lílian Magalhães Fechine; Francisco Costa Neto; José Marcílio Nicodemus; Geraldo B Silva; Leila S V Silva
Journal:  Int Urol Nephrol       Date:  2008-07-26       Impact factor: 2.370

Review 2.  Treatment of Juvenile Dermatomyositis: An Update.

Authors:  Charalampia Papadopoulou; Lucy R Wedderburn
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

3.  Reversible encephalopathy syndrome: report of 12 cases with follow-up.

Authors:  S Greco Crasto; L Rizzo; P Sardo; O Davini; R De Lucchi
Journal:  Neuroradiology       Date:  2004-10       Impact factor: 2.804

4.  Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus.

Authors:  Stephane Legriel; Fabrice Bruneel; Odile Spreux-Varoquaux; Aurelie Birenbaum; Marie Laure Chadenat; François Mignon; Nathalie Abbosh; Matthieu Henry-Lagarrigue; Laure Revault D'Allonnes; Pierre Guezennec; Gilles Troche; Jean Pierre Bedos
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.